Bridging the Gap in Knowledge to Understand Safety & Efficacy Profile of In Vivo Models for Retinal Gene Therapy
Time: 12:00 pm
day: Conference Day One
Details:
- Translatability of AAV between animal models and humans
- Distribution of viral vectors across the retina
- Assessing different routes of administration in the retina for gene therapy
